Russell Investments Group
ORMP icon

Russell Investments Group’s Oramed Pharmaceuticals ORMP Stock Holding History

Russell Investments Group’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Buy
+2,721
New +$10.8K ﹤0.01% 3883
2024
Q3 		– Sell
-250
Closed -$643 – 3766
2024
Q2 		$643 Buy
+250
New +$594 ﹤0.01% 3479
2023
Q1 		– Sell
-56,516
Closed -$680K – 3356
2022
Q4 		$680K Buy
+56,516
New +$439K ﹤0.01% 2159
2022
Q2 		– Sell
-43,013
Closed -$371K – 2948
2022
Q1 		$371K Sell
43,013
-54,097
-56% -$554K ﹤0.01% 2314
2021
Q4 		$1.39M Sell
97,110
-5,763
-6% -$120K ﹤0.01% 1996
2021
Q3 		$2.26M Buy
+102,873
New +$1.75M ﹤0.01% 1764

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Russell Investments Group's ORMP Position: Q2 2026 in Review

Russell Investments Group opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 2,721 shares worth $13.1K. The stake represents ﹤0.01% of the portfolio and ranks #3883 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in ORMP as recently as Q2 2024.

Russell Investments Group first reported a position in ORMP in Q3 2021 and has held it in 6 quarters since. The position peaked at $2.26M in Q3 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Russell Investments Group held 2,721 shares of Oramed Pharmaceuticals worth $13.1K as of Q2 2026.
  • Oramed Pharmaceuticals was a new Russell Investments Group position in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3883 holding.
  • Russell Investments Group first reported a position in Oramed Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
  • Russell Investments Group's Oramed Pharmaceuticals position peaked at $2.26M in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.